ATG Fund II LLC 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-08-10 09:20 am Unchanged | 2023-08-18 | 13D | Forte Biosciences, Inc. FBRX | ATG Fund II LLC | 58,480 4.000% | 0 (Unchanged) | Filing |
2022-08-04 4:30 pm Purchase | 2022-07-25 | 13D | Forte Biosciences, Inc. FBRX | ATG Fund II LLC | 58,480 9.900% | 58,480 (New Position) | Filing |